EP Patent

EP1428526A1 — Formulation for fast dissolution of lipophilic compounds

Assigned to Rijksuniversiteit Groningen · Expires 2004-06-16 · 22y expired

What this patent protects

The present invention relates to a pharmaceutical composition comprising at least one lipophilic compound and at least one glass of a sugar, a sugar alcohol, a mixture of sugars, a mixture of sugar alcohols or a mixture of at least one sugar and at least one sugar alcohol, wherei…

USPTO Abstract

The present invention relates to a pharmaceutical composition comprising at least one lipophilic compound and at least one glass of a sugar, a sugar alcohol, a mixture of sugars, a mixture of sugar alcohols or a mixture of at least one sugar and at least one sugar alcohol, wherein the lipophilic compound is incorporated in the sugar glass. The present invention further relates to a method for manufacturing such a pharmaceutical composition.

Drugs covered by this patent

Patent Metadata

Patent number
EP1428526A1
Jurisdiction
EP
Classification
Expires
2004-06-16
Drug substance claim
No
Drug product claim
No
Assignee
Rijksuniversiteit Groningen
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.